BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7021997)

  • 1. Blood levels of branched-chain alpha-keto acids in uremia: effect of an oral glucose tolerance test.
    Schauder P; Matthaei D; Henning HV; Scheler F; Langenbeck U
    Klin Wochenschr; 1981 Aug; 59(15):845-9. PubMed ID: 7021997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure.
    Garibotto G; Paoletti E; Fiorini F; Russo R; Robaudo C; Deferrari G; Tizianello A
    Miner Electrolyte Metab; 1993; 19(1):25-31. PubMed ID: 8345831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels of branched-chain amino acids and alpha-ketoacids in uremic patients given keto analogues of essential amino acids.
    Schauder P; Matthaei D; Henning HV; Scheler F; Langenbeck U
    Am J Clin Nutr; 1980 Jul; 33(7):1660-6. PubMed ID: 6994474
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of orally administered branched-chain alpha-keto acids.
    Dalton RN; Chantler C
    Kidney Int Suppl; 1983 Nov; 15():S11-5. PubMed ID: 6368946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-keto and alpha-hydroxy branched-chain acid interrelationships in normal humans.
    Hoffer LJ; Taveroff A; Robitaille L; Mamer OA; Reimer ML
    J Nutr; 1993 Sep; 123(9):1513-21. PubMed ID: 8360777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between branched-chain amino acids and alpha-keto acids in blood in uremia.
    Dalton RN; Chantler C
    Kidney Int Suppl; 1983 Dec; 16():S61-6. PubMed ID: 6588270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and metabolic interrelationships among branched-chain keto and amino acids in humans.
    Schauder P
    J Lab Clin Med; 1985 Dec; 106(6):701-7. PubMed ID: 4067381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum branched chain amino and keto acid response to fasting in humans.
    Schauder P; Herbertz L; Langenbeck U
    Metabolism; 1985 Jan; 34(1):58-61. PubMed ID: 3965862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of branched-chain alpha-keto-acids and lipids in sera of hypertriglyceridemic subjects.
    Penttilä IM; Herranen J; Lampainen E; Voutilainen E
    Clin Chim Acta; 1987 Dec; 170(2-3):143-9. PubMed ID: 3436049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for valine intolerance in patients with cirrhosis.
    Schauder P; Schröder K; Herbertz L; Langer K; Langenbeck U
    Hepatology; 1984; 4(4):667-70. PubMed ID: 6745855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma branched-chain ketoacids metabolism in patients with chronic renal failure after oral administration of ketosteril].
    Yang H; Zheng F; Jiang J; Hu P; Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Dec; 21(6):488-92. PubMed ID: 12567499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of insulin on blood levels of branched chain keto and amino acids in man.
    Schauder P; Schröder K; Matthaei D; Henning HV; Langenbeck U
    Metabolism; 1983 Apr; 32(4):323-7. PubMed ID: 6353139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum branched-chain amino and keto acid response to a protein-rich meal in man.
    Schauder P; Schröder K; Langenbeck U
    Ann Nutr Metab; 1984; 28(6):350-6. PubMed ID: 6393856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma amino and keto acids in chronic renal failure.
    Langer K; Fröhling PT; Diederich J; Brandl M; Lindenau K; Fekl W
    Contrib Nephrol; 1988; 65():55-9. PubMed ID: 3168462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of substitution of 2-ketoisocaproic acid and 2-ketoisovaleric acid in the diet of normal and uremic growing rats.
    Laouari D; Kamoun PP; Rocchiccioli F; Dodu C; Kleinknecht C; Broyer M
    Am J Clin Nutr; 1986 Dec; 44(6):832-46. PubMed ID: 3788832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels of branched-chain alpha-keto acids in uremia: Therapeutic implications.
    Schauder P; Matthaei D; Scheler F; Mench-Hoinowski A; Langenbeck U
    Klin Wochenschr; 1979 Aug; 57(16):825-30. PubMed ID: 502349
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin release in response to glucose is impaired in chronic renal failure.
    Franceschini R; Robaudo C; Corsini G; Cataldi A; Bruno E; Russo R; Rolandi E; Barreca T
    Biomed Pharmacother; 1998; 52(5):208-13. PubMed ID: 9755817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory action of oral thyrotropin-releasing hormone on the glucoregulatory response of the oral glucose tolerance test.
    Duntas LH; Papanastasiou L; Mantzou E; Jehle P; Mantzos I; Koutras DA
    Thyroid; 1998 Oct; 8(10):929-33. PubMed ID: 9827661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.